Plymouth, MA
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022.
idrx.comThese are collections Idrx is a part of. Click on the collection name to view similar companies.
Seed
$250,000
Pre Seed
$300,000
Series B
$120,000,000
Series A
$122,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Idrx.